IL253125A0 - Tetracaine-based formulations for use as an anesthetic - Google Patents

Tetracaine-based formulations for use as an anesthetic

Info

Publication number
IL253125A0
IL253125A0 IL253125A IL25312517A IL253125A0 IL 253125 A0 IL253125 A0 IL 253125A0 IL 253125 A IL253125 A IL 253125A IL 25312517 A IL25312517 A IL 25312517A IL 253125 A0 IL253125 A0 IL 253125A0
Authority
IL
Israel
Prior art keywords
tetracaine
anesthetic
based formulations
formulations
Prior art date
Application number
IL253125A
Other languages
Hebrew (he)
Original Assignee
St Renatus Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Renatus Llc filed Critical St Renatus Llc
Publication of IL253125A0 publication Critical patent/IL253125A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/007Syringe-type or piston-type sprayers or atomisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00Local anaesthesia; Hypothermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/008Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised by squeezing, e.g. using a flexible bottle or a bulb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/0007Special media to be introduced, removed or treated introduced into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0468Liquids non-physiological
    • A61M2202/048Anaesthetics
IL253125A 2014-12-23 2017-06-22 Tetracaine-based formulations for use as an anesthetic IL253125A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462096287P 2014-12-23 2014-12-23
PCT/US2015/000209 WO2016105482A1 (en) 2014-12-23 2015-12-23 Tetracaine-based anesthetic

Publications (1)

Publication Number Publication Date
IL253125A0 true IL253125A0 (en) 2017-08-31

Family

ID=55237886

Family Applications (1)

Application Number Title Priority Date Filing Date
IL253125A IL253125A0 (en) 2014-12-23 2017-06-22 Tetracaine-based formulations for use as an anesthetic

Country Status (11)

Country Link
EP (1) EP3236941A1 (en)
JP (1) JP2017538777A (en)
KR (1) KR20170102892A (en)
CN (1) CN107249568A (en)
AU (1) AU2015371291A1 (en)
BR (1) BR112017013373A2 (en)
CA (1) CA2971156A1 (en)
EA (1) EA201791448A1 (en)
IL (1) IL253125A0 (en)
MX (1) MX2017008516A (en)
WO (1) WO2016105482A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019191200A1 (en) 2018-03-27 2019-10-03 American Genomics, Llc Method and formulation for producing anesthesia of internal aspect of eye wall by topical application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2413899T3 (en) * 2009-04-03 2021-04-19 St Renatus Llc Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration

Also Published As

Publication number Publication date
BR112017013373A2 (en) 2018-01-02
MX2017008516A (en) 2017-09-19
WO2016105482A9 (en) 2017-08-03
EP3236941A1 (en) 2017-11-01
EA201791448A1 (en) 2017-11-30
CA2971156A1 (en) 2016-06-30
KR20170102892A (en) 2017-09-12
AU2015371291A9 (en) 2017-08-24
AU2015371291A1 (en) 2017-08-03
JP2017538777A (en) 2017-12-28
WO2016105482A1 (en) 2016-06-30
CN107249568A (en) 2017-10-13

Similar Documents

Publication Publication Date Title
IL246978A0 (en) Novel pharmaceutical formulations
GB2545368B (en) Diversion-resistant opioid formulations
IL247072A0 (en) Medical use
GB201407934D0 (en) Formulation
GB201419261D0 (en) Formulations
GB201419091D0 (en) Formulations
GB201421162D0 (en) Lanthanide complex formulations
HK1254980A1 (en) Blended formulations
PL3184492T3 (en) Antiseptic formulation
HK1232121A1 (en) Fullerene compounds as antioxidant therapy
IL248835B (en) Ceritinib formulation
IL247828A0 (en) Progesterone formulations
GB201407384D0 (en) Formulation
IL251362A0 (en) Formulation
SG11201608123VA (en) Pharmaceutical composition for external use
GB201417589D0 (en) Pharmaceutical Formulations
IL253125A0 (en) Tetracaine-based formulations for use as an anesthetic
GB201407051D0 (en) Veterinary composition
GB201402448D0 (en) Novel formulation
PL3017799T3 (en) Patient table
GB201511301D0 (en) Formulation
SG11201608124XA (en) Pharmaceutical composition for external use
IL251664A0 (en) Inhalable formulation
SG11201608122PA (en) Pharmaceutical composition for external use
GB201511478D0 (en) Blended formulations